SCHEMBL13685486

SCHEMBL13685486

Cc1ccoc1CNc1ccc2c(NS(=O)(=O)N(C)C)cccc2n1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 11/20 0.41
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 3/20 0.33
HPGD P15428 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
NR3C1 P04150 1/20 0.33
F2RL1 P55085 1/20 0.33
POLB P06746 1/20 0.33
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
TP53 P04637 1/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
ALOX15 P16050 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2245273 0.80 BRD4 (0.41) BRD4KDM4EALDH1A1SMN1; SMN2POLB
SCHEMBL12356714 0.80 NCF1 (0.42) BRD4HPGDPOLB
SCHEMBL2248077 0.67 PARP1 (0.35) BRD4ALDH1A1POLBLMNAMAPT
SCHEMBL13040635 0.67 KEAP1 (0.49) KDM4EHPGDNR3C1HTTTP53
SCHEMBL2907371 0.66 MAPT (0.45) KDM4EALDH1A1HPGDSMN1; SMN2POLB
SCHEMBL12356715 0.66 NCF1 (0.44) ALDH1A1HPGDSMN1; SMN2NR3C1LMNA
SCHEMBL2907292 0.65 NPC1 (0.42) KDM4EALDH1A1HPGDSMN1; SMN2POLB
SCHEMBL2245184 0.65 NPC1 (0.39) BRD4KDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL2901726 0.63 MAPT (0.46) BRD4KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL2901907 0.63 SMN1; SMN2 (0.42) ALDH1A1HPGDSMN1; SMN2LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2262774-B1 2-aminoquinolines as 5-HT5A receptor antagonists, their manufacture and pharmaceutical compositions thereof HOFFMANN LA ROCHE (CH) 2012-11-14 EP disclosed